$heff's $tation of $tocks & $olid DD

[kei]

IMMU reminder - 3 data presentation(s)

Thursday, December 8, 2016

Directing NK cells to Trop-2-expressing breast and other cancers, with chimeric antigen receptors (Chang, et al.)
Poster Session: Tumor Cell and Molecular Biology: Immunology and Preclinical Immunotherapy
Program Number: P2-04-17
Abstract # 246
7:30 a.m. - 9:00 a.m.
Hall 1

Friday, December 9, 2016

Sacituzumab govitecan (IMMU-132), an anti-Trop-2-SN-38 antibody-drug conjugate (ADC) for the treatment of relapsed/refractory, metastatic triple-negative breast cancer (mTNBC): Updated results (Bardia, et al.)
Poster Session: Treatment: Advanced Therapy - Targeted
Program Number: P4-22-15
Abstract # 339,
7:30 a.m. - 9:00 a.m.
Hall 1

Saturday, December 10, 2016

Enhanced efficacy of redirected T-cell therapy of TNBC with a Trop-2/CD3 bispecific antibody in combination with a checkpoint inhibitor (Rossi, et al.)
Poster Session: Treatment: Antibody-Based Regimens
Program Number: P6-14-01
Abstract # 510,
7:30 a.m. - 9:00 a.m.
Hall 1

http://finance.yahoo.com/news/immunomedics-clinical-sacituzumab-govitecan-immu-203000762.html